The luteinizing hormone (LH), folliclestimulating hormone (FSH) 
PITUITARY-TESTICULAR RESPONSES OF ESTRADIOL-173-1MPLANTED BULL CALVES TO CONTINUOUS VERSUS PULSATILE INFUSION OF LUTEINIZING HORMONE RELEASING HORMONE 1
Bruce D. Schanbacher US Department of Agriculture 2'3, Clay Center, NE 68933
Summary
The luteinizing hormone (LH), folliclestimulating hormone (FSH) and testosterone response of bull calves implanted with estradiol173to continuous and pulsatile infusion of luteinizing hormone releasing hormone (LHRH) h a s been examined. Estradiol-17~ reduced serum LH and FSH concentrations and suppressed testosterone secretion and testicular growth w h e n compared with sham-implanted bulls.
Putsatile iv infusion of LHRH [500 ng every 2 h (6 #g/d)] for a 4-wk period to estradiol-173-implanted bulls resulted in elevated mean serum LH and testosterone concentrations that were characterized by discrete secretory episodes. Mean serum FSH was also increased by LHRH pulse infusion, but LHRH-coup!ed secretory episodes were not apparen t . Continuous infusion of LHRH (6 #g/d) did not increase the low serum gonadotropin levels observed in estradiol-173-implanted calves. Testicular growth was normal in LHRH pulse-infused calves, but was
Introduction
The onset of sexual maturation (puberty) in the male bovine is poorly understood. While numerous investigators have failed to reveal age-related changes in gonadotropin secretion (MacMillan and Hafs, 1968; Karg et al., 1976; Schanbacher, 1979a) , others have identified a changing pattern of pituitary gonadotropin release (Rawlings et al., 1972; Lacroix et al., 1977; Lacroix and Pelletier, 1979a) and have emphasized the physiological importance of an episodic secretory pattern for activation of testicular function near the time of puberty (Schanbacher, 1981; Schanbaeher et al., 1982) . To further investigate the neuroendocrine mechanism(s) that governs pubertal development in the bull, the bull calf implanted with estradiol-173has been chosen as a model for study. The efficacy by which estradiol-173 inhibits the hypothalamic luteinizing hormone releasing hormone (LHRH) pulse generator, and thereby blocks pulsatile gonadotropin secretion and testicular development in young bulls, makes this model particularly useful (Schanbacher, 1981) . Recently, we reported that hourly pulsatile LHRH administration overrides the inhibitory effects of estradiol-17~ on testicular development in calves by providing Accepted September 30, 1983. an episodic mode of luteini~ing hormone (LH) 943 JOURNAL OF ANIMAL SCIENCE, Vol. 58, No. 4, 1984 stimulation to the testes (Schanbachcr et al., 1982) . While the effect of increased LH output may have been paramount to these results, our interpretations may have been premature or unjustified without information pertaining to the secretion of follicle-stimulating hormone (FSH). The following study was conducted to determine the relative importance of continuous vs pulsatile infusion of the hypothalamic releasing hormone, LHRH, on testicular development of implanted bulls and to assess the effects of the estradiol-17~and LHRH treatments on FSH secretion.
Materials and Methods
Twelve spring-born Hereford bull calves weighing 186 + 2 kg were weaned at 26 wk of age and assigned randomly to one of four experimental groups. Animals in group 1 served as sham-implanted controls while the animals in the three remaining groups were implanted at 33 wk of age with a Silastic 4 capsule containing crystalline estradiol-17fl s as described earlier (Schanbacher, 1981) . Although group 2 animals received no further treatment, the six animals in group 3 and 4 were administered 6 /~g of LHRH/d via either continuous (group 3) or pulsatile (group 4) iv infusion. Calves were placed in individual stalls for the duration of the study and equipped with tridodecylmethylammonium chloride (TDMAC)-heparinized, infusion and withdrawal jugular cannulae 6 as described previously for this purpose.
Infusions commenced immediately after a 5-h blood collection period at 34 wk of age (i.e., 3 d after being implanted with the estradiol-17/3capsule). Additional blood samples were taken at 15-rain intervals for 5 h from each of the 12 calves after 1, 2, 3 and 4 wk of treatment (i.e., 35, 36, 37 and 38 wk of age). Serum was harvested from all samples, frozen and subsequently assayed for LH and FSH (Schanbacher, 1979b) . Testosterone concentrations were determined in all samples by double-antibody radioimmunoassay , whereas estradiol-17~ concentrations were determined in weekly serum pools for 4 Dow Corning, Midland, MI. s Sigma Chemical Co., St. Louis, MO. 6 Tygon Microbore Tubing; Norton Plastics, Akron, OH.
each of the 12 calves . Changes in testicular size were determined by measuring testis diameters for each calf with calipers at the time of implanting and at 34, 35, 36, 37 and 38 wk of age.
Means of the weekly hormonal profiles were subjected to split-plot in time analysis of variance with treatment groups representing main effects and time (wk) providing the subplot (Steel and Torrie, 1960) .
Results
Mean serum LH and testosterone concentrations were significantly suppressed (P<.01) in estradiol-17~3-supplemented calves within 3 d of treatment ( figure 1, table 1 ). Serum FSH tended to be lower in the estradiolqmplanted calves at this time; however, the decrease was not significant.
The effects of the main treatments, estradiol-17/3 supplementation and LHRH infusion, were particularly pronounced. The nonimplanted, control calves maintained normal serum concentrations of LH, FSH and testosterone throughout the 4-wk study, whereas estradiol-17~-implanted calves maintained significantly reduced (P<.01) serum concentrations of all three hormones. Continuous infusion of LHRH into estradiol-17~-implanted calves (group 3) was without effect [i.e., serum concentrations of LH, FSH and testosterone remained low and similar to the concentrations observed in noninfused, estradiol-17~-implanted calves (group 2)]. In contrast, estradlol-17~implanted calves pulsed with LHRH (group 4) had markedly increased (P<.01) serum concentrations of LH, FSH and testosterone during the 4 wk of treatment when compared with the two other groups of calves implanted with estradiol-17~. Compared with nonimplanted, control calves, estradiol-17~implanted calves pulsed with LHRH had similar LH concentrations, but significantly elevated serum concentrations of FSH (P<.05) and testosterone (P<.01). Fivehour profiles of LH and testosterone from wk 0, 2 and 4 are shown for each of the four groups of calves in figure 1. The episodic nature of LH and testosterone release in control bulls is reflected by their erratic mean profiles and can be easily contrasted with the synchronous pulsatile profiles of estradiol-17/3-implanted calves infused with 500 ng of LHRH every other hour. The FSH profiles were nonpulsatile as interpreted by pulse cycle analysis, and thus are not graphically depicted. . Serum LH and testosterone profiles at 34 (wk 0), 36 (wk 2) and 38 (wk 4) wk of age for three bull calves (controls) and nine bull calves implanted with estradiol-17fl (E 2) and given iv infusions of .9% NaC1 (E 2 calves) or luteinizing hormone releasing hormone (LHRH) via continuous (E 2 + LHRH continuous calves) or pulsatile infusion (E 2 + LHRH pulse calves). The LHRH-infused calves received 6 fig of LHRH/d; either 250 ng/h continuously or 500 ng via a 30-s pulse every other hour. Each solid profile presents the mean -+ SE for serum LH of three calves, whereas the shaded area presents the mean concentrations for serum testosterone (n=3).
The mean concentrations of LH, FSH and testosterone for wk 1, 2, 3 and 4 often differed within treatment group (table 1) ; however, no particular trends were evident.
Control and estradiol-17/3-implanted calves pulsed with LHRH showed a linear increase in testis diameter during the 4 wk of treatment (figure 2). In contrast, estradiol-17/3-implanted calves and those implanted calves infused with LHRH continuously had suppressed testicular growth.
Discussion
The results of this and previous studies (Schanbacher, 1981; Schanbacher et al., 1983) provide conclusive evidence that estradiol is a potent inhibitor of gonadotropin secretion in the young male bovine. The absence of detectable episodic LH release and resultant low serum testosterone concentrations in estradiol-17;3-supplemented calves indicate that an active LHRH pulse generator in the hyopthalamus is essential for testicular growth and normal sexual development at the time of puberty (Lacroix and Pelletier, 1979b) . The inhibitory effects of estradiol-17/3 on testicular function can be overcome if LHRH is administered in a pulsatile fashion. The success of hourly pulsatile LHRH infusion was paralleled in the present study by administering the same dose (500 ng) only once ever 2 h. Interestingly, the same total dose administered over a prolonged period of time by continuous infusion was ineffective at enhancing serum hormone concentrations and stimulating testicular growth. This differential response to pulsatile vs continuous infusion of 6 tag of LHRH can likely be accounted for by the levels of LHRH achieved in serum of infused calves (B. D. Schanbacher, unpublished data). Pulseinfused calves attain measureable and presumably biologically significant quantities of LHRH in their systemic blood (and thus in pituitary portal blood) immediately after pulse infusion. On the other hand, calves infused continuously with only 6 tag of LHRH/d are never exposed to enough releasing hormone to temporarily elevate serum LHRH to levels required by the gonadotrophs for gonadotropin release. The ability of pulsatile LHRH administration to maintain or activate reproductive function has been reported by other investigators (Schanbacher and Lunstra, 1977 ; Belchetz et al., 1978; Lincoln, 1979b) .
Initiation of puberty in the infantile female rhesus monkey (Wilde et al., 1980) and reestablishment of ovarian cyclicity in seasonally anestrous ewes (McNatry et al., 1982) and postpartum anestrous beef cows (Waiters et al., 1982) has been successfully achieved by pulsatile administration of LHRH. Thus, intermittent small-dose injections of the hypothalamic releasing hormone stimulates the pituitarygonadal axis of both males and females.
Repeated injections of LHRH (gona.dotropin releasing hormone, GnRH) are known to stimulate FSH as well as LH release (Lincoln, 1979a; Waiters et al., 1982) . The increased serum concentrations of FSH in estradiol-17fl-implanted calves pulsed with LHRH (group 4), therefore, is not particularly surprising. From . Changes in testis diameter at weekly intervals after estradiol-17B (E2) treatment and iv infusion of luteinizing hormone releasing hormone (LHRH). LHRH was given either 250 ng/h continuously or 500 ng via a 30-s pulse every other hour during the 4-wk study. Mean testis diameter at the time of implanting (wk 33) was 39.5, 38.9, 39.1 and 39.6 mm for calves in group i (controls), 2 (Ea), 3 (E z + LHRH, continuous) and 4 (E a + LHRH, pulse), respectively. these results, the relative importance of increased LH (testosterone) and FSH cannot be determined. The FSH-dependent nature of testicular function and, in particular, spermatogenesis and Sertoli cell integrity (Amann and Schanbacher, 1983) , lead one to conclude that increased FSH may, in part, be responsible for the testicular growth seen in estradiol-17B-suppressed calves administered LHRH by pulse infusion.
